InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Oboyle Kevin C, Director. Officer active across 5 companies, notably NEVRO CORP. Aggregated, 13 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €74k. History available since 25 May 2021. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Oboyle Kevin C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
13,698 shares0Common StockSEC:0001193125-26-276633:0
17,333 shares0Common StockSEC:0000950170-25-098533:0
2,035 shares0Common StockSEC:0001388658-25-000184:0
8,983 shares0Common StockSEC:0001484612-25-000057:0
15,135 shares0Common StockSEC:0001484612-25-000040:0
43,396 sharesCommon StockSEC:0000950170-25-050464:0
19,169 shares0Common StockSEC:0001610717-24-000264:0
6,754 shares0Common StockSEC:0001610717-23-000078:0
103,306 shares0Common StockSEC:0001209191-22-036505:0
4,155 shares0Common StockSEC:0001567619-22-011888:0
1,000 shares@ US$83.75100.0% of flowCommon StockSEC:0001567619-21-022198:0
Canonical exit: 14 Mar 2022 (T+90)
16,870 shares0Common StockSEC:0001209191-21-040774:0
1,167 shares0Common StockSEC:0001567619-21-011222:0
13 of 13 declarations
About Oboyle Kevin C
Kevin C. O'Boyle is a Director at NEVRO CORP, CARLSMED, INC., Outset Medical, Inc., Sientra, Inc. and iRhythm Technologies, Inc. He has 13 filings in total, all in the sampled set, with EUR 74,211 of buys and EUR 0 of sells, over the period from 2021-05-26 to 2026-06-22. The modal transaction nature is Attribution.
